JPH0485301A - Amylose particle and its production - Google Patents
Amylose particle and its productionInfo
- Publication number
- JPH0485301A JPH0485301A JP2200052A JP20005290A JPH0485301A JP H0485301 A JPH0485301 A JP H0485301A JP 2200052 A JP2200052 A JP 2200052A JP 20005290 A JP20005290 A JP 20005290A JP H0485301 A JPH0485301 A JP H0485301A
- Authority
- JP
- Japan
- Prior art keywords
- amylose
- particles
- molecular weight
- starch
- average molecular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000856 Amylose Polymers 0.000 title claims abstract description 68
- 239000002245 particle Substances 0.000 title claims abstract description 67
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 229920002472 Starch Polymers 0.000 claims abstract description 38
- 239000008107 starch Substances 0.000 claims abstract description 37
- 238000005227 gel permeation chromatography Methods 0.000 claims abstract description 4
- 239000012798 spherical particle Substances 0.000 claims abstract description 4
- 238000000634 powder X-ray diffraction Methods 0.000 claims abstract description 3
- 235000019698 starch Nutrition 0.000 claims description 36
- 229920000858 Cyclodextrin Polymers 0.000 claims description 26
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 108090000790 Enzymes Proteins 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 239000000843 powder Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 5
- 239000004382 Amylase Substances 0.000 description 5
- 108010065511 Amylases Proteins 0.000 description 5
- 102000013142 Amylases Human genes 0.000 description 5
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 5
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 5
- 235000019418 amylase Nutrition 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- 238000002441 X-ray diffraction Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 108010028688 Isoamylase Proteins 0.000 description 3
- 241000178960 Paenibacillus macerans Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 108090000637 alpha-Amylases Proteins 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000001116 FEMA 4028 Substances 0.000 description 2
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 2
- 102100022624 Glucoamylase Human genes 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 108010019077 beta-Amylase Proteins 0.000 description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 2
- 229960004853 betadex Drugs 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 2
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 241000193752 Bacillus circulans Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000605056 Cytophaga Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 241000519695 Ilex integra Species 0.000 description 1
- DKNPRRRKHAEUMW-UHFFFAOYSA-N Iodine aqueous Chemical compound [K+].I[I-]I DKNPRRRKHAEUMW-UHFFFAOYSA-N 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000006082 mold release agent Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 235000019685 rice crackers Nutrition 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01019—Cyclomaltodextrin glucanotransferase (2.4.1.19)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
- C08B30/20—Amylose or amylopectin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/16—Preparation of compounds containing saccharide radicals produced by the action of an alpha-1, 6-glucosidase, e.g. amylose, debranched amylopectin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明はアミロース粒子とその製造方法に関し、更に詳
細に巳よ、特定の形状、X線回折図形、分子量を有する
アミロース粒子と、シクロデキストリンまたは澱粉を含
有する水溶液にシクロマルトデキストリン・グルカノト
ランスフエラーゼを作用きせて該水溶液に不溶性のアミ
ロース粒子を生成せしめ、このアミロース粒子を採取す
ることを特徴とするアミロース粒子の製造方法に関する
。Detailed Description of the Invention [Industrial Application Field] The present invention relates to amylose particles and a method for producing the same, and more particularly, the present invention relates to amylose particles having a specific shape, X-ray diffraction pattern, and molecular weight, and cyclodextrin or The present invention relates to a method for producing amylose particles, which comprises applying cyclomaltodextrin glucanotransferase to an aqueous solution containing starch to produce amylose particles insoluble in the aqueous solution, and collecting the amylose particles.
[従来の技術]
アミロースの製造方法は、次に示すごとく種々の方法か
知られている。[Prior Art] Various methods for producing amylose are known as shown below.
(1)ティー・ゼイ・ショック(’T、J、5choc
h )がジャーナル・オブ・アメリカン・ケミカル・ソ
サイエテイ(Journal of American
Chemical 5ociety) Vol、64
.2957 (1942年)で報告しているブタノール
による夜合体沈R法。(1) T, J, 5choc
h) is the Journal of American Chemical Society.
Chemical 5ociety) Vol, 64
.. 2957 (1942), the night coalescence precipitation R method using butanol.
(2)ケイ・エイチ・マイヤー(に、)1.Meyer
)等が、ヘルベティ力・キミ力・アクタ()lelve
ticaChimica Acta) Vol、24.
378 (1951年)で報告している温水による抽出
法。(2) K. H. Meyer (2) 1. Meyer
) etc. are Helveti force, Kimi force, Acta () level
ticaChimica Acta) Vol, 24.
378 (1951), an extraction method using hot water.
(3)バス(Bus )等が、特公昭32−8975号
公報、米国特許2,822,305および米国特許2,
829,990で開示している硫酸マグネシウムによる
塩析法。(3) Bus etc. are disclosed in Japanese Patent Publication No. 32-8975, U.S. Patent No. 2,822,305 and U.S. Patent No. 2,
Salting out method using magnesium sulfate disclosed in No. 829,990.
(4)桟木等が特公昭54−21420号公報で開示し
ているプルラナーゼ、イソアミラーゼなどのの扮枝切酵
素による加水分解法。(4) A hydrolysis method using debranching enzymes such as pullulanase and isoamylase, which is disclosed by Sanki et al. in Japanese Patent Publication No. 54-21420.
(5)ハンス・ヘンダー(Hans Benderlが
、力−ボハイドレイト・リサーチ(Carbohydr
ateResearch) Vol、65.85−97
(197g年)で報告しているシクロマルトデキスト
リン・グルカノトランスフェラーゼによる受容体への糖
転移反応法。(5) Hans Benderl (Hans Benderl), Force-Bohydrate Research (Carbohydrate Research)
ateResearch) Vol, 65.85-97
(197g), a method of glycosyltransfer reaction to receptors using cyclomaltodextrin glucanotransferase.
しかしながら、(1)、(2)および、(3)の方法で
は澱粉からの収率が、通常25W/W%未満と低いだけ
でなく、原料澱粉の種類やロットによって、アミロース
の品質、収率か安定せず、また、アミロペクチンの混入
の恐れもある。However, in methods (1), (2), and (3), not only the yield from starch is low, usually less than 25 W/W%, but also the quality and yield of amylose vary depending on the type and lot of raw starch. In addition, there is a risk of contamination with amylopectin.
(4)の方法では、澱粉からの収率が80W/W%以上
と高いものの、長鎖アミロースと短鎖アミロースとの混
合物でしか得られず、通常、この長鎖、短鎖アミロース
の煩雑な分別工程を必要とするっまだ、澱粉技切酵素に
よる未分#*の混入の恐れもある。Although the method (4) has a high yield of 80 W/W% or more from starch, it can only be obtained as a mixture of long-chain amylose and short-chain amylose, and usually the complicated process of combining long-chain amylose and short-chain amylose is difficult. Even though a separation process is required, there is a risk of contamination of unfractionated #* by starch cutting enzymes.
(5)の方法では、アミロースの生成濃度が低く、その
回収にメタノールなどの有機沈澱剤を必要とするにもか
かわらず、その収率は30v/讐%未満と低い。In method (5), although the concentration of amylose produced is low and an organic precipitant such as methanol is required for its recovery, the yield is low at less than 30 v/h%.
[発明が解決しようとする課題]
従来のアミロース製造方法の欠点を解消し、分子量の比
較的そろった高品質のアミロース粒子とそれを安定して
容易に高収率に製造する方法の確立が強く望まれている
。[Problems to be solved by the invention] There is a strong need to establish high-quality amylose particles with relatively uniform molecular weights and a method for producing them stably, easily, and at high yields by eliminating the drawbacks of conventional amylose production methods. desired.
[課題を解決するための手段]
本発明は、上記欠点を解消するためになされたものであ
って、とりわけシクロマルトデキストリン・グルカノト
ランスフエラーゼ(EC2,4,1,19)を使用して
、新規アミa−ス粒子とその製造方法の確立を目差して
鋭意研究した。[Means for Solving the Problems] The present invention was made to solve the above-mentioned drawbacks, and in particular, by using cyclomaltodextrin glucanotransferase (EC2, 4, 1, 19). , conducted intensive research with the aim of establishing a new amyas particle and its manufacturing method.
その結果、シクロデキストリンまたは澱粉の比較的高濃
度水溶液にシクロマルトデキストリン・グルカノトラン
スフエラーゼ(以下、CG T −aseと略称する。As a result, cyclomaltodextrin glucanotransferase (hereinafter abbreviated as CGT-ase) was added to a relatively highly concentrated aqueous solution of cyclodextrin or starch.
)を比較的低温で作用きせることにより、該水溶液中に
新規アミロース粒子が沈澱生成することを見い出し、こ
れを採取することによって容易に高品質のアミロース粒
子が高収率に製造しうろことを見い出し、本発明を完成
した。) was found to form a precipitate in the aqueous solution by reacting it at a relatively low temperature, and it was discovered that by collecting the precipitate, high-quality amylose particles could be easily produced at a high yield. , completed the invention.
また、本発明は、下記の特長を有していることも判明し
た。It has also been found that the present invention has the following features.
(1ン反応溶液中に不溶性のアミロース粒子を沈澱生成
することから、その分離、回収が容易であり、高価なメ
タノール、ブタノールなどの有機沈澱剤が不要である−
0
(2)原料からの収率を50W/W%以上の高収車にす
ることも容易である。(Since insoluble amylose particles are precipitated in the 1-N reaction solution, their separation and recovery are easy, and expensive organic precipitants such as methanol and butanol are not required.)
0 (2) It is also easy to make a high yield vehicle with a yield of 50 W/W% or more from raw materials.
(3)原料の違い、CG T−aseの起源の違い、作
用温度、作用量、作用時間などの条件を変えることによ
り、生成するアミロース粒子の分子量を調整することも
できる。(3) The molecular weight of the produced amylose particles can also be adjusted by changing conditions such as differences in raw materials, origins of CG T-ase, action temperature, action amount, and action time.
本発明に用いる原料シクロデキストリンは、α−シクロ
デキストリン、β−シクロデキストリシ、γ−シクロデ
キヌトリンのいずれか一種または二種以上の混合物であ
ってもよい。また、シクロデキストリンは、市販品を用
いることも、澱粉にCGT−aseを作用させて生成し
たものを用いることも随意である。この際、シクロデキ
ストリンにグルコースや低分子のオリゴ糖などが共存す
るならば、できるだけ除去して作用させるのが望ましい
。The raw material cyclodextrin used in the present invention may be any one of α-cyclodextrin, β-cyclodextrin, and γ-cyclodextrin, or a mixture of two or more thereof. Furthermore, as the cyclodextrin, it is optional to use a commercially available product or one produced by acting CGT-ase on starch. At this time, if glucose, low-molecular oligosaccharides, etc. coexist with the cyclodextrin, it is desirable to remove them as much as possible before the cyclodextrin acts.
また、澱粉にCG T−aseと澱粉枝切酵素とを作用
させてシクロデキストリンを生成させるとともにアミロ
ース粒子を生成させることも有利に実施できる。It is also advantageous to cause CG T-ase and starch debranching enzyme to act on starch to generate cyclodextrin and amylose particles.
また、本発明に用いる澱粉は、馬鈴薯澱粉、せ薯澱粉、
タピオカ澱粉などの地下澱粉であっても、とうもろこし
澱粉、小麦澱粉、米澱粉などの地上澱粉であってもよい
。澱粉にCG T−aseを作用させるには、澱粉乳に
CG T−aseを添加して加熱し、澱粉を固化液化さ
せてもよく、また、必要ならば、予め、澱粉を酸または
α−アミラーゼで低DE。In addition, the starch used in the present invention includes potato starch, horsetail starch,
It may be underground starch such as tapioca starch, or above ground starch such as corn starch, wheat starch, rice starch. In order to cause CG T-ase to act on starch, CG T-ase may be added to starch milk and heated to solidify and liquefy the starch.If necessary, starch may be treated with acid or α-amylase in advance. And low DE.
望ましくは、DE1未満に液化した後にCGT−ase
を作用させてもよい。Desirably, CGT-ase after liquefaction to less than DE1
may be applied.
本発明に使用するC G T−aseは、公知のバチル
ス・ステアロサーモフィラス(Bacillus st
earothermophilus) 、バチルス・サ
ーキュランス(BaCillus circulans
) 、バチルス・マセランス(Baaillus ma
cerans)などのバチルス属、クレブシーラ争ニュ
ーモニアエ(Klebsiella pneumoni
aelなどのクレブシーラ属などに属する微生物由来の
酵素が用いられる。とりわけ、澱粉を加熱糊化する際に
しても使用できる好熱性のバチルス・ステアロサーモフ
ィラス由来のCG T−aseか有利に利用できる。ま
た、澱粉枝切酵素は、プルラナーゼ(EC3,2,1,
41)として公知のアエロバクタ−(Aerobact
er )属、バチルス属などに属する微生物由来の酵素
が、イソアミラーゼ(EC3,2,1,68)として、
公知のシュードモナス(Pseudo+5onas )
属、フラボバクテリウム(F 1avobacter
ium I属、チトファーガ(Cytophaga )
属に属する微生物由来の酵素が有利に利用できる。これ
らの酵素は、本発明の目的を達成しきえすればよく、必
ずしも精製して使用する必要はなく、通常は、培養上清
や、これの部分精製酵素が用いられる。また、必要に応
じて、固定化して用いることも随意である。The CGT-ase used in the present invention is a well-known Bacillus stearothermophilus (Bacillus stearothermophilus).
Bacillus circulans
), Bacillus macerans
Bacillus species such as Bacillus cerans, Klebsiella pneumoniae
Enzymes derived from microorganisms belonging to the genus Klebscilla, such as AEL, are used. In particular, thermophilic CG T-ase derived from Bacillus stearothermophilus, which can also be used to heat and gelatinize starch, can be advantageously used. In addition, starch debranching enzymes include pullulanase (EC3, 2, 1,
41) known as Aerobacter
Enzymes derived from microorganisms belonging to the genus Bacillus, Bacillus, etc. are used as isoamylases (EC3, 2, 1, 68).
Known Pseudomonas (Pseudo+5onas)
Genus, Flavobacterium
ium I genus, Cytophaga
Enzymes derived from microorganisms belonging to the genus can be advantageously used. These enzymes do not necessarily need to be purified before use, as long as they can achieve the purpose of the present invention, and culture supernatants or partially purified enzymes thereof are usually used. Moreover, it is also optional to use it after immobilization, if necessary.
より具体的に述べると、本発明においては、シクロデキ
ストリンまたは澱粉を約10〜50W/W%含有する水
溶液にCG T−aseを、固形物ダラム当り1〜1
、000単位、温度約5〜100℃、PH3〜9から選
ばれる条件で適宜の時間作用きせることにより、アミロ
ース粒子を該水溶液に析出、沈澱生成させる。More specifically, in the present invention, CG T-ase is added to an aqueous solution containing about 10 to 50 W/W% of cyclodextrin or starch in an amount of 1 to 1 per solid duram.
, 000 units, temperature of approximately 5 to 100° C., and pH of 3 to 9 for an appropriate period of time, amylose particles are deposited in the aqueous solution to form a precipitate.
澱粉乳を使用する場合には、例えば、澱粉にCGT −
ase 、または、CG T−aseと澱粉枝切酵素と
を加え、温度70〜100℃に加熱して、澱粉を糊化、
液化させた後、60℃以下、望ましくは、5〜50℃に
冷却し、必要に応じて、CG T−aseを追加し、5
〜500時間反応を進め、アミロース粒子を沈澱生成さ
せる。このアミロース粒子は、濾過または遠心分離によ
り容易に回収できる。When using starch milk, for example, CGT-
Add T-ase or CG T-ase and starch debranching enzyme and heat to 70 to 100°C to gelatinize the starch.
After liquefaction, cool to 60°C or less, preferably 5 to 50°C, add CG T-ase as necessary,
The reaction is allowed to proceed for ~500 hours to precipitate amylose particles. The amylose particles can be easily recovered by filtration or centrifugation.
このようにして得られたアミロース粒子の理化学的性質
を調べたところ、(1)ほぼ球形の粒子が単一状態で、
または複数結合した状態で存在し、それらの直径または
長径が約2〜10μ−であり、(2)粉末xW1回折に
より澱粉のB形図形を与え、(3)ゲル浸透クロマトグ
ラフィーにより、数平均分子量(Mn )か約4,00
0〜7,000 (グルコースの平均重合度として約2
5〜43個)、重量平均分子量(Mw)/数平均分子量
(Mn)が約1.4〜1.7を与え、(4)沃素呈色が
青紫〜青色となり、(5)β−アミラーゼの作用により
理論量のマルトースを生成することが判明した。When we investigated the physical and chemical properties of the amylose particles obtained in this way, we found that (1) almost spherical particles were in a single state;
or exists in a plurality of bonded states, and their diameter or major axis is about 2 to 10 μ-; (2) powder x W1 diffraction gives a B-shaped starch pattern; and (3) gel permeation chromatography shows that the number average molecular weight is (Mn) or about 4,00
0 to 7,000 (approximately 2 as the average degree of polymerization of glucose)
5 to 43), the weight average molecular weight (Mw)/number average molecular weight (Mn) is about 1.4 to 1.7, (4) the iodine coloration is bluish-purple to blue, and (5) the β-amylase It was found that the reaction produced a theoretical amount of maltose.
CG T−aseによる反応で得られたアミロース粒子
を、更に、溶解、沈澱を繰り返すなどの方法で精製する
ことも随意である。例えば、アミロース粒子を水に加熱
溶解し、これを冷却、沈j!させ、濾過または遠心分離
し、乾燥して白色粉末状のアミロース粒子を採取する。It is also optional to further purify the amylose particles obtained by the reaction using CG T-ase by repeating dissolution and precipitation. For example, amylose particles are heated and dissolved in water, cooled, and precipitated. The mixture is filtered or centrifuged, and dried to collect white powdery amylose particles.
また、得られるアミロース粒子を公知の方法により、更
に、微粉末化したり、顆粒化したりすることも随意であ
る。It is also optional to further pulverize or granulate the obtained amylose particles by a known method.
このようにして得られるアミロース粒子は、粉末品では
流動性良好、難吸湿性であり、水に加熱溶解したものは
、アミラーゼの作用を受は易く、冷却により固化し易い
性質を有する。The amylose particles obtained in this manner have good fluidity and low hygroscopicity in powder form, and when dissolved by heating in water, they are easily affected by the action of amylase and easily solidify when cooled.
これらの性質を利用して、本発明のアミロース粒子は、
例えば、ゼリー菓子、餅菓子、米菓、パン、クツキー、
錠菓、打粉などとして食品分野、粉剤、錠剤、ペースト
剤などとして医薬品分野、化粧品分野などに、更には、
離型剤、付着防止剤、増量剤、賦形剤、フィルム素材な
どとして各種分野に広く利用される。Utilizing these properties, the amylose particles of the present invention are
For example, jelly sweets, mochi sweets, rice crackers, bread, kutski,
It is used in the food field as tablets, powder, etc., in the pharmaceutical field, cosmetics field, etc. as powder, tablets, paste, etc.
It is widely used in various fields as a mold release agent, anti-adhesion agent, filler, excipient, film material, etc.
また、高品質のアミロース粒子が安定して生産できるこ
とから、アミラーゼ測定用基質として臨床検査などに有
利に利用できる。Furthermore, since high-quality amylose particles can be stably produced, it can be advantageously used as a substrate for amylase measurement in clinical tests.
以下、実験を用いて、本発明の詳細な説明する。Hereinafter, the present invention will be explained in detail using experiments.
実験 1 アミロース粒子の生成に及ぼす基質濃度の影
響
α−シクロデキストリンを各種濃度に溶解した基質溶液
に、バチルス・ステアロサーモフィラス由来のCG T
−ase (■林原生物化学研究所販売)をシクロデキ
ストリングラム当り50単位使用し、温度30℃、pH
5,5で20時間作用させ、生成したアミロース粒子を
遠心分離にて回収して収″i (v/W%)を求めた。Experiment 1 Effect of substrate concentration on the production of amylose particles CGT derived from Bacillus stearothermophilus was added to a substrate solution containing α-cyclodextrin dissolved in various concentrations.
-ase (sold by Hayashibara Biochemistry Research Institute) at 50 units per cyclodextrin ram, temperature 30℃, pH
5.5 for 20 hours, the produced amylose particles were collected by centrifugation, and the yield i (v/W%) was determined.
また、このアミ口−ス粒子を東ソー株式会社販売のTS
K−GEL G40QOP讐およびG3000P讐を連
結して使用し、分子量標準物質として昭和電工株式会社
販売の5hodex 5TANDARDP−82を使用
するゲル浸透クロマトグラフィーにかけ、数平均分子量
fan)を求めた。結果は。In addition, this amigosu particle is used as TS sold by Tosoh Corporation.
K-GEL G40QOP and G3000P were used in conjunction and subjected to gel permeation chromatography using 5hodex 5TANDARDP-82 sold by Showa Denko Co., Ltd. as a molecular weight standard to determine the number average molecular weight (fan). Result is.
表1に示した。It is shown in Table 1.
表
表1の結果より、アミロース粒子の生成は基質濃度に依
存し、基質濃度が高いほどアミロース粒子の生成量は増
加し、15W/W%以上の濃度で50W/IJ%以上の
高収率であった。生成したアミロース粒子の分子量は、
はとんど同じであった。From the results shown in Table 1, the production of amylose particles depends on the substrate concentration, and the higher the substrate concentration, the greater the amount of amylose particles produced. there were. The molecular weight of the generated amylose particles is
were almost the same.
実験2 アミロース粒子の生成に及ぼす温度の影響
α−シクaデキストリンの25v/す%溶液にバチルス
・ステアロサーモフィラス由来のCGT−aseをシク
ロデキストリングラム当り50単位、pH5,5で各種
温度で20時間作用させ、アミロース粒子を回収した。Experiment 2 Effect of temperature on the formation of amylose particles CGT-ase derived from Bacillus stearothermophilus was added to a 25v/su% solution of α-cyclodextrin at 50 units per cyclodextrin gram at various temperatures at pH 5.5. After 20 hours of action, amylose particles were collected.
得られたアミロース粒子の収率や分子量の測定結果を表
2に示した。Table 2 shows the measurement results of the yield and molecular weight of the obtained amylose particles.
表 2
実験3 アミロース粒子の生成に支ぼすCGTase起
源の比較
α−シクロテ゛キストリン、γ−シクロテ゛キストリン
の25v/ソ%?容+Piにバチルス・ステアロサーモ
フィラス、バチルス・マセランス由来のCGT−ase
をシクロデキストリングラム当り50単位、pH5,5
、Ar14o℃で20時間作用させ、得られたアミロー
ス粒子の収率や分子量、沃素呈色の測定を行なった。そ
の結果を、表3に示した。Table 2 Experiment 3 Comparison of CGTase sources that support the production of amylose particles 25v/so% of α-cyclodextrin and γ-cyclodextrin? CGT-ase derived from Bacillus stearothermophilus and Bacillus macerans in the volume + Pi
50 units per cyclodextrin gram, pH 5.5
, Ar was applied at 14° C. for 20 hours, and the yield, molecular weight, and iodine coloration of the obtained amylose particles were measured. The results are shown in Table 3.
表2の結果より、アミロース粒子の生成は温度に依存し
、温度が低いほどアミロース粒子の生成量は増大し、5
0℃以下か好適であった。生成したアミロース粒子の分
子量は、温度に影響された。From the results in Table 2, the production of amylose particles is dependent on temperature, and the lower the temperature, the greater the amount of amylose particles produced.
The temperature was preferably below 0°C. The molecular weight of the produced amylose particles was influenced by temperature.
表
表3に示したように、基質の種類、酵素の起源により、
生成するアミロース粒子の収率や分子量、沃素呈色は異
なっており、この違いを利用することにより所望のアミ
ロース粒子の!!遥か可能になる。As shown in Table 3, depending on the type of substrate and the origin of the enzyme,
The yield, molecular weight, and iodine coloration of the produced amylose particles are different, and by taking advantage of these differences, the desired amylose particles can be produced! ! It becomes far more possible.
以下、実施例を述べる。Examples will be described below.
実施例 1
α−シクロデキストリンの25v/讐%水溶液に、バチ
ルス・ステアロサーモフィラス由来のCGT−aseを
シクロデキストリングラム当り50単位の割合で加え、
pH5,5,30℃で20時間反応させた。生成したア
ミロース粒子を遠心分離機にて回収した。これを水で2
回遠心洗浄し、40℃で一夜真空乾燥し、アミロース粒
子を約84W/W%の収率で得た。Example 1 CGT-ase derived from Bacillus stearothermophilus was added to a 25% aqueous solution of α-cyclodextrin at a rate of 50 units per cyclodextrin,
The reaction was carried out at pH 5, 5, and 30° C. for 20 hours. The generated amylose particles were collected using a centrifuge. Add this with water 2
The mixture was washed by centrifugation and vacuum dried at 40° C. overnight to obtain amylose particles with a yield of about 84 W/W%.
本品の理化学的性質を調べたところ、次の通りであった
。The physical and chemical properties of this product were investigated and found to be as follows.
(1)粒子径
走差型電子顕微鏡にて2 、000倍に拡大して調べた
ところ、図1に示すように、ほぼ球形の粒子が単一状態
で、または複数結合した状態で確認きれ、それらの直径
または長径は約2〜10μIであった。(1) Particle size When examined using a scanning electron microscope at a magnification of 2,000 times, as shown in Figure 1, almost spherical particles could be confirmed in a single state or in a multiple bonded state. Their diameter or major axis was approximately 2-10 μI.
(2)粉末X線解析
XS回折装置(理学電機株式会社製造、商品名ガイガー
フレックスRAD−II B 1CuKα線使用)にて
対照の澱粉と本発明のアミロース粒子を粉末法で調べた
。結果は、図2に示した。■は澱粉のA形図形であり、
(4りは澱粉のB形図形である。■は本発明のアミロー
ス粒子のX線回折図であり、■と同し澱粉のB形図形を
与えることか判明した。(2) Powder X-ray Analysis The control starch and the amylose particles of the present invention were examined by the powder method using an XS diffractometer (manufactured by Rigaku Denki Co., Ltd., trade name: Geigerflex RAD-II B 1CuKα rays). The results are shown in Figure 2. ■ is the A-shaped figure of starch,
(4) is the B-shaped pattern of starch. ■ is an X-ray diffraction pattern of the amylose particles of the present invention, and it was found that it gives the same B-shaped pattern of starch as in (■).
(3)分子量
ゲル濾過クロマトグラフィーにより、分子量(数平均分
子量(Mn)および重量平均分子量(My) )を調べ
たところ、それらの値は、それぞれ5 、300および
g、oooてあった。(3) Molecular Weight When the molecular weight (number average molecular weight (Mn) and weight average molecular weight (My)) was examined by gel filtration chromatography, the values were 5, 300 and g, ooo, respectively.
従って、そのMy/Mnは約1.5で、このことは、分
子量分布幅の狭い高品質のアミロースであることを意味
する。Therefore, its My/Mn is about 1.5, which means that it is a high quality amylose with a narrow molecular weight distribution.
(4)比旋光度
[a]20163° (l=1、c=0.9.0.5ト
NaOH)(5)赤外線吸収スペクトル
KBr錠剤法で渕定し、結果は、図3に示した。(4) Specific optical rotation [a] 20163° (l = 1, c = 0.9.0.5t NaOH) (5) Infrared absorption spectrum determined by KBr tablet method, and the results are shown in Figure 3. .
(6)沃素呈色
沃素−沃化カリウム溶液で青紫に呈色し、その最大吸収
波長(λl1aXlは、57Onm付近であった。(6) Iodine coloring The sample was colored bluish-purple with an iodine-potassium iodide solution, and its maximum absorption wavelength (λl1aXl) was around 57 Onm.
(7)アミラーゼ分解
サツマイモ由来のβ−アミラーゼ(生化学工業株式会社
、結晶標品)によって、加水分解され、理論量のマルト
ースを生成することから、本アミロース粒子は、実質的
にα−1,4グルコシド結合から成っているものと判断
される。(7) Amylase decomposition Since it is hydrolyzed by sweet potato-derived β-amylase (Seikagaku Corporation, crystal specimen) to produce a theoretical amount of maltose, the present amylose particles are substantially α-1, It is thought to consist of 4 glucoside bonds.
実施例2
7−シクロデキストリンの25W/W%水溶液にバチル
ス・マセランス由来のCG T−aseをシクロデキス
トリングラム当り70単位加え、pH5,7,40℃で
20時間作用させた。生成したアミロース粒子を実施例
1と同様に洗浄、乾燥してアミロース粒子を収率的66
W/W%で得た。Example 2 70 units of Bacillus macerans-derived CGT-ase per cyclodextrin gram was added to a 25W/W% aqueous solution of 7-cyclodextrin, and the mixture was allowed to act at pH 5, 7, and 40°C for 20 hours. The produced amylose particles were washed and dried in the same manner as in Example 1 to obtain amylose particles with a high yield of 66%.
Obtained in W/W%.
本品の数平均分子量(Mn)、重量平均分子量(My)
は、それぞれ4 、700.6,500で、そのMy/
Mnは約1.4であった。Number average molecular weight (Mn), weight average molecular weight (My) of this product
are 4 and 700.6,500 respectively, and their My/
Mn was about 1.4.
本品の他の理化学的性質は、実施例1と同様であった。Other physical and chemical properties of this product were the same as in Example 1.
実施例3
β−シクロデキストリンの20讐/V%含有懸濁液にバ
チルス・ステアロサーモフィラス由来のCG T−as
eをシクロデキストリングラム当り200単位加え、p
H5,7に維持し、50℃で4時間作用させた後、冷却
し、40℃で10時間、30℃で10時間、計24時間
作用させ、生成したアミ0−ス粒子を実施例1と同様に
採取し、収率的60i+l/l/%で得た。Example 3 CG T-as derived from Bacillus stearothermophilus was added to a suspension containing 20%/V of β-cyclodextrin.
Add 200 units of e per cyclodextrin ram, add p
After maintaining the temperature at H5.7 and reacting at 50°C for 4 hours, cooling, and reacting at 40°C for 10 hours and 30°C for 10 hours, for a total of 24 hours, the produced amylose particles were treated as Example 1. A similar sample was obtained with a yield of 60i+l/l/%.
氷晶の数平均分子量(Mn) 、重量平均分子量(My
)はそれぞれ5 、200.7.900て、そのMy/
Mnは約1.5であった。Number average molecular weight (Mn), weight average molecular weight (My
) are 5 and 200.7.900 respectively, and their My/
Mn was about 1.5.
氷晶の他の理化学的性質は、実施例1と同様であった。Other physical and chemical properties of the ice crystals were the same as in Example 1.
実施例4
20W/W%とうもろ、::LM粉乳(p)16.OL
=調整)にバチルス・ステアロサーモフィラス由来の好
熱性CG T−aseを固形物ダラム当り1単位加え、
90℃で20分間液化を行なった9、この液化液を70
℃に冷却し、CG T−aseを固形物ダラム当り5単
位加え、24時間反応きせてシクロデキストリンを生成
きせた。この反応液を100℃で20分間維持して、C
G T−aseを失活させ、次いで、pH4,5に調整
し、グルコアミラーゼを固形物当り10単位加え、55
℃で200時間反応せな。この反応液を100℃10分
間維持して、グルコアミラーゼを失活させ、濾過し活性
炭にて脱色し、濃縮した。Example 4 20W/W% corn, ::LM milk powder (p) 16. OL
= Adjustment), added 1 unit of thermophilic CG T-ase derived from Bacillus stearothermophilus per solid duram,
Liquefaction was carried out at 90°C for 20 minutes9, and this liquefied liquid was heated to 70°C.
The mixture was cooled to 0.degree. C., 5 units of CG T-ase was added per solid duram, and the reaction was allowed to proceed for 24 hours to produce cyclodextrin. This reaction solution was maintained at 100°C for 20 minutes to
G T-ase was inactivated, then the pH was adjusted to 4.5, glucoamylase was added at 10 units per solid, and 55
Incubate at ℃ for 200 hours. This reaction solution was maintained at 100° C. for 10 minutes to inactivate glucoamylase, filtered, decolorized with activated carbon, and concentrated.
本濃縮液を、特公昭62−51120号公報に開示され
ている方法に準じて、ナトリウム型強酸性カチオン交換
樹脂を充填したカラムクロマトグラフィーにかけ、グル
コースを除去し、α−β−17−シクロデキストリン混
合物を、溶液状で収率的25W/IJ%で得た。This concentrated solution was subjected to column chromatography packed with a sodium-type strongly acidic cation exchange resin according to the method disclosed in Japanese Patent Publication No. 62-51120 to remove glucose and to remove α-β-17-cyclodextrin. The mixture was obtained in solution with a yield of 25 W/IJ%.
本溶液を、濃度約35W/W%にし、バチルス・ステア
ロサーモフィラス由来のCG T−aseをシクロデキ
ストリングラム当り50単位加え、pH5,7に維持し
、65℃で4時間、次いで冷却して、40℃で10時間
、30℃で10時間、計24時間作用させ、生成したア
ミロース粒子を実施例1と同様に採取して、シクロデキ
ストリン混合物当り収率的85W/W%を得た。This solution was brought to a concentration of approximately 35 W/W%, 50 units of CG T-ase derived from Bacillus stearothermophilus was added per cyclodextrin gram, the pH was maintained at 5.7, and the mixture was heated at 65°C for 4 hours and then cooled. The mixture was allowed to react at 40° C. for 10 hours and at 30° C. for 10 hours for a total of 24 hours, and the produced amylose particles were collected in the same manner as in Example 1 to obtain a yield of 85 W/W% based on the cyclodextrin mixture.
氷晶の数平均分子104nl 、重量平均分子量(My
)はそれぞれ6,600.10,500で、そのMy/
)4nは約1.6であった。The number average molecular weight of ice crystals is 104nl, the weight average molecular weight (My
) are 6,600.10,500 respectively, and their My/
)4n was approximately 1.6.
氷晶の他の理化学的性′i!ば、実施例1と同様であっ
た。Other physical and chemical properties of ice crystals'i! In other words, it was the same as in Example 1.
実施例5
25W/W%馬鈴薯II粉乳(PH6,0ニ調整)ニハ
チルス・ステアロサーモフィラス由来の好熱性CG T
−aseを固形物ダラム当り2単位加え、90tで、2
0分間液化を行なった。この液化液を55℃に冷却し、
P)15.5に調整した後、CGT−ase1イソアミ
ラーゼ(株式会社林原生物化学研究所販売)を固形物ダ
ラム当り、それぞれ100単位ずつ加え、3時間作用き
せ、シクロデキストリンを生成させな後、冷却し、40
℃に6時間、30t’に17時間、計26時間作用させ
、生成したアミローフ粒子を実施例1と同様に採取し、
澱粉当り収率約55讐/ソ%で得た。Example 5 25W/W% Potato II powdered milk (pH adjusted to 6.0) Thermophilic CG T derived from Nihatillus stearothermophilus
-ase was added at 2 units per solid duram, and at 90 tons, 2 units
Liquefaction was performed for 0 minutes. This liquefied liquid was cooled to 55°C,
P) After adjusting to 15.5, add 100 units of each of CGT-ase1 isoamylase (sold by Hayashibara Biochemical Research Institute Co., Ltd.) per solid duram, let it work for 3 hours, and do not generate cyclodextrin. Cool, 40
℃ for 6 hours and 30t' for 17 hours, a total of 26 hours, and the generated Amyloaf particles were collected in the same manner as in Example 1.
A yield of about 55% starch was obtained.
氷晶の数平均分子量(Mn) 、重量平均分子量(Mv
)は、それぞれ5 、400.9,200て、そのMy
/Mnは約1.7であった。Number average molecular weight (Mn), weight average molecular weight (Mv) of ice crystals
) are 5, 400.9, 200 respectively, and their My
/Mn was about 1.7.
氷晶の他の理化学的性質は、実施例1と同様であった。Other physical and chemical properties of the ice crystals were the same as in Example 1.
し発明の効果1
本文で述べたごとく、本発明の新規アミロース粒子は、
比較的分子量のそろった高品質の粒子で、シクロデキス
トリンまたは澱粉にシクロデキストリン・グルカノトラ
ンスフェラーゼを作用させた反応溶液中に沈澱生成する
ことから分離、回収が容易であり、高価なメタノール、
ブタノールなどの有機沈澱剤が不要である。Effect of the invention 1 As stated in the main text, the novel amylose particles of the present invention are
They are high-quality particles with a relatively uniform molecular weight, and are easy to separate and recover because they form a precipitate in a reaction solution in which cyclodextrin or starch is reacted with cyclodextrin glucanotransferase.
Organic precipitants such as butanol are not required.
また、原料からの収率を50W/W%以上に高めること
も容易である。Further, it is also easy to increase the yield from the raw materials to 50 W/W% or more.
更に、原料の違い、CG T−aseの起源の違い、作
用濃度、作用量などの反応条件を変えることによって、
生成するアミロース粒子の分子量を調整できることもき
わめて好都合である。Furthermore, by changing the reaction conditions such as differences in raw materials, differences in the origin of CG T-ase, working concentration, and working amount,
It is also very advantageous to be able to adjust the molecular weight of the amylose particles produced.
このようにして得られる新規アミa−ス粒子は、粉末品
では、流動性良好、難吸湿性であり、水に加熱溶解した
ものは、アミラーゼの作用を受は易く、冷却により固化
し易い性質を有する。The new amylase particles obtained in this way have good fluidity and low hygroscopicity in the powder form, and when heated and dissolved in water, they are easily affected by the action of amylase and solidify by cooling. has.
これらの性質を利用して、食品、医薬品、化粧品などの
素材として有利に利用されることにより、これら産業に
おける工業的意義はきわめて大きい。Utilizing these properties, they can be advantageously used as materials for foods, medicines, cosmetics, etc., and therefore have great industrial significance in these industries.
図1は、本発明の一例として、アミロース粒子の電子顕
微鏡による拡大写真(2,ooo倍)である。
図2は、澱粉と本発明のアミロース粒子の粉末X線回折
図で、■は澱粉のA形図形であり、■は澱粉のB形図形
であり、■は本発明のアミロース粒子のX線回折図であ
る。
図3は、本発明の一例として、アミロース粒子の赤外線
吸収スペクトルである。FIG. 1 is an enlarged photograph (2,000 times magnification) of amylose particles taken by an electron microscope as an example of the present invention. Figure 2 is a powder X-ray diffraction diagram of starch and amylose particles of the present invention, where ■ is the A-shaped pattern of starch, ■ is the B-shaped pattern of starch, and ■ is the X-ray diffraction pattern of the amylose particles of the present invention. It is a diagram. FIG. 3 shows an infrared absorption spectrum of amylose particles as an example of the present invention.
Claims (2)
た状態で存在し、それらの直径または長径が約2〜10
μmであり、粉末X線回折により澱粉のB形図形を与え
、ゲル浸透クロマトグラフィーにより数平均分子量が約
4,000〜7,000、重量平均分子量/数平均分子
量が約1.4〜1.7を与えることを特徴とするアミロ
ース粒子。(1) Approximately spherical particles exist in a single state or in a plurality bonded state, and their diameter or major axis is about 2 to 10
Pm, the B-shaped pattern of starch is obtained by powder X-ray diffraction, and the number average molecular weight is approximately 4,000-7,000 by gel permeation chromatography, and the weight average molecular weight/number average molecular weight is approximately 1.4-1. Amylose particles characterized by giving 7.
にシクロマルトデキストリン・グルカノトランスフエラ
ーゼを作用させて該水溶液に不溶性のアミロース粒子を
生成せしめ、このアミロース粒子を採取することを特徴
とするアミロース粒子の製造方法。(2) A process for producing amylose particles, which comprises making amylose particles insoluble in the aqueous solution act on an aqueous solution containing cyclodextrin or starch to produce amylose particles that are insoluble in the aqueous solution, and collecting the amylose particles. Production method.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2200052A JP2926434B2 (en) | 1990-07-26 | 1990-07-26 | Amylose particles and method for producing the same |
| GB9116133A GB2247242B (en) | 1990-07-26 | 1991-07-25 | Granular amylose and its preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2200052A JP2926434B2 (en) | 1990-07-26 | 1990-07-26 | Amylose particles and method for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0485301A true JPH0485301A (en) | 1992-03-18 |
| JP2926434B2 JP2926434B2 (en) | 1999-07-28 |
Family
ID=16418031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2200052A Expired - Fee Related JP2926434B2 (en) | 1990-07-26 | 1990-07-26 | Amylose particles and method for producing the same |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2926434B2 (en) |
| GB (1) | GB2247242B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020230238A1 (en) | 2019-05-13 | 2020-11-19 | 昭和産業株式会社 | Modifier, modification composition comprising said modifier, food and beverage, drug, cosmetic, industrial product, feed, medium or fertilizer using same, and method for modifying said products |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5409726A (en) | 1990-02-20 | 1995-04-25 | A. E. Staley Manufacturing Co. | Method of preparing reduced fat foods |
| US5395640A (en) | 1990-02-20 | 1995-03-07 | A.E. Staley Manufacturing Company | Method of preparing reduced fat foods |
| US5374442A (en) | 1990-02-20 | 1994-12-20 | A. E. Staley Manufacturing Company | Method of preparing reduced fat foods |
| US5372835A (en) | 1990-02-20 | 1994-12-13 | A. E. Staley Manufacturing Company | Method of preparing reduced fat foods |
| US5436019A (en) | 1990-02-20 | 1995-07-25 | A. E. Staley Manufacturing Co. | Method of preparing reduced fat foods |
| US5368878A (en) | 1990-02-20 | 1994-11-29 | A. E. Staley Manufacturing Company | Reduced fat meat products |
| JPH05506776A (en) | 1990-02-20 | 1993-10-07 | エー.イー.ステーリー マニュファクチュアリング カンパニー | Method for producing low-fat food |
| US5378491A (en) | 1990-02-20 | 1995-01-03 | A. E. Staley Manufacturing Co. | Method of preparing a starch hydrolysate, an aqueous starch hydrolysate dispersion, method of preparing a food containing a starch hydrolysate, and a food formulation containing a starch hydrolysate |
| US5387426A (en) | 1990-02-20 | 1995-02-07 | A.E. Staley Manufacturing Company | Method of preparing reduced fat foods |
| US5376399A (en) | 1992-05-15 | 1994-12-27 | A.E. Staley Manufacturing Co. | Reduced fat cremes |
| USH1395H (en) | 1992-05-22 | 1995-01-03 | A. E. Staley Manufacturing Company | Composition and method of preparing reduced fat spreads |
| USH1394H (en) | 1992-05-22 | 1995-01-03 | A. E. Staley Manufacturing Company | Method of preparing reduced fat spreads |
| NL9300131A (en) * | 1993-01-22 | 1994-08-16 | Avebe Coop Verkoop Prod | Method for fractionating starch. |
| FR2716199B1 (en) * | 1994-02-15 | 1996-04-26 | Roquette Freres | Process for the manufacture of a starch hydrolyzate with a low polymolecularity index, a new starch hydrolyzate thus obtained and its use in peritoneal dialysis. |
| DE19737481A1 (en) * | 1997-08-28 | 1999-03-04 | Hoechst Ag | Microparticles containing spherical linear polysaccharides |
| DE19839216C1 (en) * | 1998-08-28 | 2000-01-20 | Aventis Res & Tech Gmbh & Co | Preparation of biocompatible, biodegradable water-insoluble polysaccharide microparticles, used e.g. as fillers for polymers or in diagnostic tests |
| DE19860371A1 (en) * | 1998-12-28 | 2000-06-29 | Aventis Res & Tech Gmbh & Co | Cosmetic or medical preparation for topical use |
| AU752746B2 (en) * | 1998-12-28 | 2002-09-26 | Celanese Ventures Gmbh | Sun protection product with microparticles on the basis of water-insoluble linear polyglucan |
| DE19860373B4 (en) * | 1998-12-28 | 2004-02-19 | Celanese Ventures Gmbh | Oral care products and use of spherical microparticles |
| DE19902917C2 (en) * | 1999-01-26 | 2001-03-29 | Aventis Res & Tech Gmbh & Co | Water-insoluble linear polysaccharides for filtration |
| US20080286410A1 (en) * | 2007-03-06 | 2008-11-20 | Richmond Patricia A | Production of Resistant Starch Product |
| JP6388475B2 (en) * | 2011-03-18 | 2018-09-12 | バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated | Peritoneal dialysis solution containing glucose polymer |
| CN113678933B (en) * | 2021-08-10 | 2023-03-28 | 江南大学 | Method for enhancing gel property of starch soft sweets by enzyme method and application thereof |
| CN114874467B (en) * | 2022-06-16 | 2025-06-24 | 中国海洋大学 | A monodisperse type 3 resistant starch nanoparticle with uniform particle size and preparation method thereof |
| CN118141943A (en) * | 2024-03-14 | 2024-06-07 | 上海市第十人民医院 | A starch iodine nano material and its preparation method and application |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4587332A (en) * | 1984-02-28 | 1986-05-06 | Ogilvie Mills Ltd. | Modified wheat "B" starch for corrugating adhesives |
| US4551177A (en) * | 1984-04-23 | 1985-11-05 | National Starch And Chemical Corporation | Compressible starches as binders for tablets or capsules |
-
1990
- 1990-07-26 JP JP2200052A patent/JP2926434B2/en not_active Expired - Fee Related
-
1991
- 1991-07-25 GB GB9116133A patent/GB2247242B/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020230238A1 (en) | 2019-05-13 | 2020-11-19 | 昭和産業株式会社 | Modifier, modification composition comprising said modifier, food and beverage, drug, cosmetic, industrial product, feed, medium or fertilizer using same, and method for modifying said products |
| KR20210118176A (en) | 2019-05-13 | 2021-09-29 | 소와산교주식회사 | Modifier, composition for modification containing the modifier, and food, beverage, pharmaceutical, cosmetic, industrial product, feed, medium, or fertilizer using the same, and method for modifying the product |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9116133D0 (en) | 1991-09-11 |
| JP2926434B2 (en) | 1999-07-28 |
| GB2247242B (en) | 1994-04-06 |
| GB2247242A (en) | 1992-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0485301A (en) | Amylose particle and its production | |
| EP0710674B1 (en) | Method for producing a glucan having cyclic structure | |
| JP3957684B2 (en) | Glucan production method and preparation method thereof | |
| JP5828589B2 (en) | Industrial production method of branched glucan having cyclic structure | |
| EP1873254B1 (en) | Branched starch, process for production thereof, and use thereof | |
| AU2002307701A1 (en) | Production method and preparation method of glucans | |
| JP2001294601A (en) | Highly branched starch and method for producing the same | |
| NZ525811A (en) | Resistant starch prepared by isoamylase debranching of low amylose starch | |
| Krithika et al. | Modifiction of starch: A review of various techniques | |
| JP3150266B2 (en) | Glucan having cyclic structure and method for producing the same | |
| US6248566B1 (en) | Glucan having cyclic structure and method for producing the same | |
| EP3564269B1 (en) | Polymer glucan having low digestion rate | |
| DE69521450T2 (en) | Cyclic structured glucans and process for their preparation | |
| JPS6346201A (en) | Multiply branched cyclodextrin and its production | |
| JP5726499B2 (en) | Method for producing branched glucan having a cyclic structure | |
| JP3025869B2 (en) | Highly transparent starch gelatinizing liquid | |
| JP4011102B2 (en) | Glucan production method and preparation method thereof | |
| JPS6013678B2 (en) | Method for producing cyclodextrin | |
| JPH0329374B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090514 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100514 Year of fee payment: 11 |
|
| LAPS | Cancellation because of no payment of annual fees |